Literature DB >> 21245396

Disruption of contact lens-associated Pseudomonas aeruginosa biofilms formed in the presence of neutrophils.

Danielle M Robertson1, Quinn M Parks, Robert L Young, Jennifer Kret, Katie R Poch, Kenneth C Malcolm, David P Nichols, Michelle Nichols, Meifang Zhu, H Dwight Cavanagh, Jerry A Nick.   

Abstract

PURPOSE: To evaluate the capacity of neutrophils to enhance biofilm formation on contact lenses by an infectious Pseudomonas aeruginosa (PA) corneal isolate. Agents that target F-actin and DNA were tested as a therapeutic strategy for disrupting biofilms formed in the setting of neutrophils in vitro and for limiting the infectious bioburden in vivo.
METHODS: Biofilm formation by infectious PA strain 6294 was assessed in the presence of neutrophils on a static biofilm plate and on unworn etafilcon A soft contact lenses. A d-isomer of poly(aspartic acid) was used alone and with DNase to reduce biofilm formation on test contact lenses. The gentamicin survival assay was used to determine the effectiveness of the test compound in reducing subsequent intracellular bacterial load in the corneal epithelium in a contact lens infection model in the rabbit.
RESULTS: In a static reactor and on hydrogel lenses, PA biofilm density was enhanced 30-fold at 24 hours in the presence of neutrophils (P < 0.0001). The combination of DNase and anionic poly(aspartic acid) reduced the PA biofilms formed in the presence of activated neutrophils by 79.2% on hydrogel contact lenses (P < 0.001). An identical treatment resulted in a 41% reduction in internalized PA in the rabbit corneal epithelium after 24 hours (P = 0.03).
CONCLUSIONS: These results demonstrate that PA can exploit the presence of neutrophils to form biofilm on contact lenses within a short time. Incorporation of F-actin and DNA represent a mechanism for neutrophil-induced biofilm enhancement and are targets for available agents to disrupt pathogenic biofilms formed on contact lenses and as a treatment for established corneal infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245396      PMCID: PMC3088567          DOI: 10.1167/iovs.10-6469

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  57 in total

Review 1.  Molecular regulation of neutrophil apoptosis and potential targets for therapeutic strategy against the inflammatory process.

Authors:  Paul Hofman
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2004-03

2.  Corneal epithelial homeostasis following daily and overnight contact lens wear.

Authors:  Patrick M Ladage; Kazuaki Yamamoto; Ling Li; David H Ren; W Matthew Petroll; James V Jester; H Dwight Cavanagh
Journal:  Cont Lens Anterior Eye       Date:  2002-03       Impact factor: 3.077

Review 3.  Role of innate and adaptive immunity in the pathogenesis of keratitis.

Authors:  Linda D Hazlett
Journal:  Ocul Immunol Inflamm       Date:  2005 Apr-Jun       Impact factor: 3.070

4.  Internalization of Pseudomonas aeruginosa is mediated by lipid rafts in contact lens-wearing rabbit and cultured human corneal epithelial cells.

Authors:  Naoka Yamamoto; Nobutaka Yamamoto; Matthew W Petroll; H Dwight Cavanagh; James V Jester
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

5.  The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. Microbial Keratitis Study Group.

Authors:  O D Schein; R J Glynn; E C Poggio; J M Seddon; K R Kenyon
Journal:  N Engl J Med       Date:  1989-09-21       Impact factor: 91.245

6.  Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide.

Authors:  C Haslett; L A Guthrie; M M Kopaniak; R B Johnston; P M Henson
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

7.  Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa.

Authors:  Minjian Ni; David J Evans; Samuel Hawgood; E Margot Anders; Robert A Sack; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

8.  Aging and PMN response to P. aeruginosa infection.

Authors:  K A Kernacki; R P Barrett; S A McClellan; L D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-09       Impact factor: 4.799

9.  Increased resistance of contact lens-related bacterial biofilms to antimicrobial activity of soft contact lens care solutions.

Authors:  Loretta B Szczotka-Flynn; Yoshifumi Imamura; Jyotsna Chandra; Changping Yu; Pranab K Mukherjee; Eric Pearlman; Mahmoud A Ghannoum
Journal:  Cornea       Date:  2009-09       Impact factor: 2.651

10.  The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses.

Authors:  E C Poggio; R J Glynn; O D Schein; J M Seddon; M J Shannon; V A Scardino; K R Kenyon
Journal:  N Engl J Med       Date:  1989-09-21       Impact factor: 91.245

View more
  18 in total

1.  Residence in biofilms allows Burkholderia cepacia complex (Bcc) bacteria to evade the antimicrobial activities of neutrophil-like dHL60 cells.

Authors:  Mark P Murphy; Emma Caraher
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

2.  Pseudomonas aeruginosa infectious keratitis in a high oxygen transmissible rigid contact lens rabbit model.

Authors:  Cynthia Wei; Meifang Zhu; W Matthew Petroll; Danielle M Robertson
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

3.  Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products.

Authors:  Silvia M Caceres; Kenneth C Malcolm; Jennifer L Taylor-Cousar; David P Nichols; Milene T Saavedra; Donna L Bratton; Samuel M Moskowitz; Jane L Burns; Jerry A Nick
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

4.  The impact of cellular debris on Pseudomonas aeruginosa adherence to silicone hydrogel contact lenses and contact lens storage cases.

Authors:  Geoffrey W Burnham; H Dwight Cavanagh; Danielle M Robertson
Journal:  Eye Contact Lens       Date:  2012-01       Impact factor: 2.018

5.  Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.

Authors:  David P Nichols; Silvia Caceres; Lindsay Caverly; Cori Fratelli; Sun Ho Kim; Ken Malcolm; Katie R Poch; Milene Saavedra; George Solomon; Jennifer Taylor-Cousar; Samuel Moskowitz; Jerry A Nick
Journal:  J Surg Res       Date:  2013-02-24       Impact factor: 2.192

6.  Human Tear Fluid Reduces Culturability of Contact Lens-Associated Pseudomonas aeruginosa Biofilms but Induces Expression of the Virulence-Associated Type III Secretion System.

Authors:  Yvonne T Wu; Connie Tam; Lucia S Zhu; David J Evans; Suzanne M J Fleiszig
Journal:  Ocul Surf       Date:  2016-09-23       Impact factor: 5.033

Review 7.  The effects of silicone hydrogel lens wear on the corneal epithelium and risk for microbial keratitis.

Authors:  Danielle M Robertson
Journal:  Eye Contact Lens       Date:  2013-01       Impact factor: 2.018

Review 8.  Microbial keratitis: could contact lens material affect disease pathogenesis?

Authors:  David J Evans; Suzanne M J Fleiszig
Journal:  Eye Contact Lens       Date:  2013-01       Impact factor: 2.018

Review 9.  Contact lens-related corneal infection: Intrinsic resistance and its compromise.

Authors:  Suzanne M J Fleiszig; Abby R Kroken; Vincent Nieto; Melinda R Grosser; Stephanie J Wan; Matteo M E Metruccio; David J Evans
Journal:  Prog Retin Eye Res       Date:  2019-11-20       Impact factor: 21.198

10.  Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival.

Authors:  Kenneth C Malcolm; E Michelle Nichols; Silvia M Caceres; Jennifer E Kret; Stacey L Martiniano; Scott D Sagel; Edward D Chan; Lindsay Caverly; George M Solomon; Paul Reynolds; Donna L Bratton; Jennifer L Taylor-Cousar; David P Nichols; Milene T Saavedra; Jerry A Nick
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.